Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for NPK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 10.82%
March 31, 2026 5.58%
December 31, 2025 9.15%
September 30, 2025 4.60%
June 30, 2025 4.28%
March 31, 2025 7.34%
December 31, 2024 15.39%
September 30, 2024 8.80%
June 30, 2024 7.14%
March 31, 2024 8.57%
December 31, 2023 13.37%
September 30, 2023 8.44%
June 30, 2023 6.97%
March 31, 2023 11.04%
December 31, 2022 1.91%
September 30, 2022 12.81%
June 30, 2022 8.66%
March 31, 2022 4.80%
December 31, 2021 3.23%
September 30, 2021 4.73%
June 30, 2021 10.67%
March 31, 2021 11.10%
December 31, 2020 13.16%
September 30, 2020 12.92%
June 30, 2020 14.53%
Date Value
March 31, 2020 12.53%
December 31, 2019 12.35%
September 30, 2019 18.86%
June 30, 2019 11.36%
March 31, 2019 9.32%
December 31, 2018 13.88%
September 30, 2018 7.64%
June 30, 2018 13.60%
March 31, 2018 14.31%
December 31, 2017 13.89%
September 30, 2017 11.81%
June 30, 2017 11.99%
March 31, 2017 13.69%
December 31, 2016 24.38%
September 30, 2016 10.42%
June 30, 2016 11.42%
March 31, 2016 9.87%
December 31, 2015 11.36%
September 30, 2015 8.92%
June 30, 2015 8.91%
March 31, 2015 8.03%
December 31, 2014 8.80%
September 30, 2014 5.37%
June 30, 2014 4.72%
March 31, 2014 5.42%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Axon Enterprise, Inc. 3.25%
Moog, Inc. 13.62%
Safer Shot, Inc. --
Byrna Technologies, Inc. -61.56%
AAR Corp. 5.46%